标题
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
作者
关键词
-
出版物
Applied Sciences-Basel
Volume 10, Issue 16, Pages 5704
出版商
MDPI AG
发表日期
2020-08-18
DOI
10.3390/app10165704
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
- (2019) Chandrasekaran Padmapriyadarsini et al. BMJ Open
- Revolutionary new treatment regimens for multidrug-resistant tuberculosis
- (2019) Timothy D McHugh et al. LANCET INFECTIOUS DISEASES
- Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
- (2019) Edyta M. Grzelak et al. JOURNAL OF ANTIBIOTICS
- Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
- (2019) Kelly E. Dooley et al. PLOS MEDICINE
- Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity
- (2019) Manjunatha M. R et al. ACS Medicinal Chemistry Letters
- Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery
- (2019) Kuldeep K. Roy et al. Expert Opinion on Drug Discovery
- Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis
- (2019) Richa Mishra et al. Science Translational Medicine
- In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
- (2018) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hit Generation in TB Drug Discovery: From Genome to Granuloma
- (2018) Tianao Yuan et al. CHEMICAL REVIEWS
- Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
- (2018) Yongge Liu et al. TUBERCULOSIS
- Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects
- (2017) Yewon Choi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
- (2017) Subramanyam J. Tantry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity
- (2016) Sudhir Landge et al. ChemMedChem
- Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
- (2016) Alimuddin Zumla et al. LANCET INFECTIOUS DISEASES
- Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
- (2016) Subramanyam J. Tantry et al. MedChemComm
- Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase
- (2015) Sudhir Landge et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Towards host-directed therapies for tuberculosis
- (2015) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Linezolid for XDR-TB — Final Study Outcomes
- (2015) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the potential of adjunct therapy in tuberculosis
- (2015) Geetha Vani Rayasam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
- (2015) K. Mdluli et al. Cold Spring Harbor Perspectives in Medicine
- Linezolid for Treating Tuberculosis: A Delicate Balancing Act
- (2015) Gary Maartens et al. EBioMedicine
- Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors
- (2014) B. K. Kishore Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
- (2014) Monalisa Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic and Pharmacodynamic Evaluation of AZD5847 in a Mouse Model of Tuberculosis
- (2014) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of AZD5847 against Geographically Diverse Clinical Isolates of Mycobacterium tuberculosis
- (2014) Jim Werngren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase
- (2014) Vikas Patil et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sutezolid. Oxazolidinone antibacterial, treatment of tuberculosis
- (2014) J.-P. Lanoix et al. DRUGS OF THE FUTURE
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors
- (2014) Maruti Naik et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
- (2014) Maruti Naik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis
- (2014) Shahul Hameed P et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
- (2014) Manoranjan Panda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
- (2014) Rohit Vashisht et al. Journal of Translational Medicine
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing
- (2014) Shahul Hameed P et al. ACS Medicinal Chemistry Letters
- Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis
- (2013) Matthew W. Carroll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship andIn VivoEfficacy in a Mouse Model of Tuberculosis
- (2013) Shahul Hameed P et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
- (2013) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy
- (2013) Ramesh R. Kale et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis
- (2013) Shashank Deoghare INDIAN JOURNAL OF PHARMACOLOGY
- Structural and Biochemical Characterization of Compounds InhibitingMycobacterium tuberculosisPantothenate Kinase
- (2013) Christofer Björkelid et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B
- (2013) Manoj G. Kale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis
- (2012) Pravin S. Shirude et al. ACS Chemical Biology
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation
- (2012) Addepalli Venkata Ramani et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents
- (2012) Pravin S. Shirude et al. ACS Medicinal Chemistry Letters
- Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
- (2010) Dhiraj Kumar et al. CELL
- TMC207: the first compound of a new class of potent anti-tuberculosis drugs
- (2010) Alberto Matteelli et al. Future Microbiology
- Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-d-ribose 2′-epimerase DprE1 ofMycobacterium tuberculosis
- (2010) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- (2010) Neel R Gandhi et al. LANCET
- Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
- (2009) Kathy N. Williams et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Linezolid in the Treatment of Multidrug‐Resistant Tuberculosis
- (2009) G. F. Schecter et al. CLINICAL INFECTIOUS DISEASES
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Design, synthesis, and evaluation of novel ethambutol analogues
- (2008) Raghunandan Yendapally et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started